DWP10292

· Daewoong Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DWP10292, covering 2014-02-25 to 2016-06-02. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects [Phase 1]